Annual Vitamin D3 Dosing: 100,000 IU IM
If administering 100,000 IU vitamin D3 intramuscularly every 3 months (quarterly), the total annual dose is 400,000 IU per year.
Dosing Framework Based on Guidelines
The guideline evidence provides clear context for intermittent high-dose vitamin D3 regimens 1:
- 100,000 IU every 3 months is explicitly recommended as equivalent to 800 IU/day for maintenance supplementation in at-risk populations (dark-skinned individuals, those ≥65 years, institutionalized subjects) 1
- This quarterly regimen equals 400,000 IU annually (100,000 IU × 4 doses)
Safety Considerations
Critical safety threshold: Hypercalcemia in healthy adults occurs only with daily intake >100,000 IU or serum 25(OH)D levels >100 ng/mL 1. The quarterly dosing of 100,000 IU is fundamentally different from daily dosing and falls well within safety parameters.
However, newer evidence raises concerns about very high intermittent doses 2:
- Doses >100,000 IU per administration may increase fracture risk (RR 1.14 [95% CI, 1.02-1.27])
- Annual single doses of 500,000 IU resulted in adverse outcomes 1
- Daily, weekly, or monthly strategies are preferred over less frequent high-dose boluses 1
Practical Dosing Algorithm
For quarterly IM administration:
- 100,000 IU every 3 months = 400,000 IU/year (acceptable per guidelines)
- Monitor 25(OH)D levels to maintain 30-80 ng/mL range 1
- Avoid exceeding 100,000 IU per single dose 2
Alternative safer approaches:
- Monthly: 25,000-50,000 IU IM (300,000-600,000 IU/year)
- Weekly: 50,000 IU for 8 weeks, then maintenance 3
Key Caveats
Vitamin D3 (cholecalciferol) is superior to D2 (ergocalciferol) for intermittent dosing, as D3 maintains serum levels longer 1, 4
Higher-risk populations (obesity, malabsorption, medications affecting vitamin D metabolism) require 2-3× higher doses 3
Monitor serum calcium during high-dose supplementation, especially in patients with granulomatous diseases or primary hyperparathyroidism 3
Dosing intervals matter: Intervals >12 weeks show higher fall risk compared to 1-12 week intervals 2
The 100,000 IU quarterly regimen totaling 400,000 IU annually is guideline-supported but represents the upper limit of recommended intermittent dosing frequency.